Dowling & Yahnke’s Veracyte VCYT Stock Holding History

Dowling & Yahnke’s Portfolio VCYT Stock Details VCYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$996K	Buy	+60,000	New	+$1.35M	0.05%	222
2021 Q4	–	Sell	-4,400	Closed	-$204K	–	387
2021 Q3	$204K	Sell	4,400 -4,400	-50%	-$192K	0.01%	361
2021 Q2	$352K	Sell	8,800 -4,427	-33%	-$189K	0.02%	290
2021 Q1	$711K	Hold	13,227	–	–	0.05%	224
2020 Q4	$647K	Buy	+13,227	New	+$613K	0.05%	228

Other funds holding VCYT

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Dowling & Yahnke's VCYT Position: Q3 2022 in Review

Dowling & Yahnke opened a new position in Veracyte (VCYT) in Q3 2022: 60,000 shares worth $996K. The stake represents 0.05% of the portfolio and ranks #222 among its holdings. This is a return to the name: Dowling & Yahnke previously reported a position in VCYT as recently as Q3 2021.

Dowling & Yahnke first reported a position in VCYT in Q4 2020 and has held it in 5 quarters since. 208 funds tracked by Wall St. Rank hold VCYT as of Q3 2022.

Dowling & Yahnke held 60,000 shares of Veracyte worth $996K as of Q3 2022.
Veracyte was a new Dowling & Yahnke position in Q3 2022.
Veracyte made up 0.05% of Dowling & Yahnke's portfolio in Q3 2022, its #222 holding.
Dowling & Yahnke first reported a position in Veracyte in Q4 2020 and has held it in 5 quarters since.
208 funds tracked by Wall St. Rank held Veracyte as of Q3 2022.

Based on Dowling & Yahnke's 13F filing for Q3 2022, filed 3 Nov 2022.